[go: up one dir, main page]

WO2005045062A3 - Gene expression and polymorphisms associated with lung cancer - Google Patents

Gene expression and polymorphisms associated with lung cancer Download PDF

Info

Publication number
WO2005045062A3
WO2005045062A3 PCT/US2004/035690 US2004035690W WO2005045062A3 WO 2005045062 A3 WO2005045062 A3 WO 2005045062A3 US 2004035690 W US2004035690 W US 2004035690W WO 2005045062 A3 WO2005045062 A3 WO 2005045062A3
Authority
WO
WIPO (PCT)
Prior art keywords
gene expression
lung cancer
polymorphisms associated
gene
las1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2004/035690
Other languages
French (fr)
Other versions
WO2005045062A2 (en
Inventor
Ming You
Zhongqiu Zhang
Manabu Futamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ohio State University Research Foundation
Original Assignee
Ohio State University Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ohio State University Research Foundation filed Critical Ohio State University Research Foundation
Priority to EP20040796566 priority Critical patent/EP1753882A2/en
Priority to AU2004288177A priority patent/AU2004288177A1/en
Priority to CA002543965A priority patent/CA2543965A1/en
Publication of WO2005045062A2 publication Critical patent/WO2005045062A2/en
Publication of WO2005045062A3 publication Critical patent/WO2005045062A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Methods are provided relating to the identification and treatment of cancers that involve altered expression of the Lung Adenoma Susceptibility-1 Gene (Las1) gene and/or its product, the Las1 protein.
PCT/US2004/035690 2003-10-27 2004-10-27 Gene expression and polymorphisms associated with lung cancer Ceased WO2005045062A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP20040796566 EP1753882A2 (en) 2003-10-27 2004-10-27 Gene expression and polymorphisms associated with lung cancer
AU2004288177A AU2004288177A1 (en) 2003-10-27 2004-10-27 Gene expression and polymorphisms associated with lung cancer
CA002543965A CA2543965A1 (en) 2003-10-27 2004-10-27 Gene expression and polymorphisms associated with lung cancer

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51467303P 2003-10-27 2003-10-27
US60/514,673 2003-10-27

Publications (2)

Publication Number Publication Date
WO2005045062A2 WO2005045062A2 (en) 2005-05-19
WO2005045062A3 true WO2005045062A3 (en) 2005-07-28

Family

ID=34572767

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/035690 Ceased WO2005045062A2 (en) 2003-10-27 2004-10-27 Gene expression and polymorphisms associated with lung cancer

Country Status (4)

Country Link
EP (1) EP1753882A2 (en)
AU (1) AU2004288177A1 (en)
CA (1) CA2543965A1 (en)
WO (1) WO2005045062A2 (en)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DOSEFF ET AL.: "LAS1 is an essential nuclear protein involved in cell morphogenesis and cell surface growth", GENETICS, vol. 141, November 1995 (1995-11-01), pages 857 - 871, XP002987299 *

Also Published As

Publication number Publication date
AU2004288177A1 (en) 2005-05-19
WO2005045062A2 (en) 2005-05-19
CA2543965A1 (en) 2005-05-19
EP1753882A2 (en) 2007-02-21

Similar Documents

Publication Publication Date Title
WO2004050707A3 (en) Tumor-specific recognition molecules
WO2002071928A3 (en) Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
WO2007031222A3 (en) Identification of tumor-associated antigens for diagnosis and therapy
WO2007076423A3 (en) INHIBITORS OF Akt ACTIVITY
WO2003050243A3 (en) Novel genes encoding colon cancer antigens
WO2004106495A3 (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
SI2400018T1 (en) In tumours differentially expressed gene products and use of the same.
WO2005034732A3 (en) Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
WO2003000012A3 (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer
WO2009053041A3 (en) Identification of tumor-associated markers for diagnosis and therapy
WO2001002568A3 (en) Human genes and gene expression products
WO2004018999A3 (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
WO2004080418A3 (en) Nucleic acid compounds for inhibiting angiogenesis and tumor growth
AU2003226676A1 (en) Methods and compositions for the identification, assessment, and therapy of small cell lung cancer
WO2005000087A3 (en) Gene products differentially expressed in cancerous colon cells and their methods of use ii
WO2006009765A3 (en) Methods for the identification and use of compounds suitable for the treatment of drug resistant cancer cells
WO2004058158A3 (en) Treatment of metastatic cancer with the b-subunit of shiga toxin
WO2006037462A3 (en) Cancer markers
WO2005019269A3 (en) Techniques and compositions for the diagnosis and treatment of cancer (muc1)
WO2005026205A3 (en) Genetic products which are differentially expressed in tumours and use thereof
GB0418388D0 (en) Cell therapy
AU2003235791A1 (en) Gene products differentially expressed in cancerous breast cells and their methods of use
WO2005045062A3 (en) Gene expression and polymorphisms associated with lung cancer
WO2007076320A8 (en) Compounds
WO2002081640A3 (en) Gene shinc-1 and diagnostic and therapeutic uses thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2543965

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2004796566

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2004288177

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2004288177

Country of ref document: AU

Date of ref document: 20041027

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2004288177

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2004796566

Country of ref document: EP

WWR Wipo information: refused in national office

Ref document number: 2004796566

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2004796566

Country of ref document: EP